Cargando…

Dress syndrome following carbamazepine exposure: A very early onset

INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous drug reaction characterised by both systemic and cutaneous clinical manifestation with a mean latency period of 3.9 weeks. OBJECTIVES: To underline the importance of an early diagnosis of DRESS SYNDROME...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraiem, M., Charfi, N., Mhiri, E., Gassara, I., Omri, S., Smaoui, N., Feki, R., Zouari, L., Thabet, J. Ben, Bouali, M. Maalej, Maalej, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479778/
http://dx.doi.org/10.1192/j.eurpsy.2021.2047
_version_ 1784790868005224448
author Kraiem, M.
Charfi, N.
Mhiri, E.
Gassara, I.
Omri, S.
Smaoui, N.
Feki, R.
Zouari, L.
Thabet, J. Ben
Bouali, M. Maalej
Maalej, M.
author_facet Kraiem, M.
Charfi, N.
Mhiri, E.
Gassara, I.
Omri, S.
Smaoui, N.
Feki, R.
Zouari, L.
Thabet, J. Ben
Bouali, M. Maalej
Maalej, M.
author_sort Kraiem, M.
collection PubMed
description INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous drug reaction characterised by both systemic and cutaneous clinical manifestation with a mean latency period of 3.9 weeks. OBJECTIVES: To underline the importance of an early diagnosis of DRESS SYNDROME. METHODS: We reported a case of carbamazepine induced DRESS syndrome with atypical chronology of manifestations. RESULTS: A 43-year-old man with no previous known medical history was admitted in psychiatry. He experienced a relapse of schizoaffective symptoms. In the last three years, the patient was treated by Valproic acid as a mood stabilizer. Because of the unavailability of this molecule, carbamazepine was prescribed in combination with antipsychotics. Three days later, the patient developed a high fever, hypotension, a pruritus, a facial oedema, a skin rash associated to lymphadenopathy. Laboratory findings showed a lymphopenia, eosinophilia and elevated liver chemistries. In order to define the case, RegiSCAR scoring system was used, and our case is categorized as probable with a score of five. Carbamazepine was discontinued upon clinical manifestationsand the patient was treated with systemic antihistaminic treatment associated to methylprednisolone with a good outcome. After 3 weeks, clinical and biological improvement were noted. CONCLUSIONS: Despite the absence of a delayed onset, typically between 3 weeks and 3months, we can diagnose dress syndrome 3 days after carbamazepine intake. This case highlights that psychiatrists should be aware of the risk of early onset dress syndrome associated with carbamazepine and they should monitor for warning symptoms from treatment initiation. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9479778
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94797782022-09-29 Dress syndrome following carbamazepine exposure: A very early onset Kraiem, M. Charfi, N. Mhiri, E. Gassara, I. Omri, S. Smaoui, N. Feki, R. Zouari, L. Thabet, J. Ben Bouali, M. Maalej Maalej, M. Eur Psychiatry Abstract INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous drug reaction characterised by both systemic and cutaneous clinical manifestation with a mean latency period of 3.9 weeks. OBJECTIVES: To underline the importance of an early diagnosis of DRESS SYNDROME. METHODS: We reported a case of carbamazepine induced DRESS syndrome with atypical chronology of manifestations. RESULTS: A 43-year-old man with no previous known medical history was admitted in psychiatry. He experienced a relapse of schizoaffective symptoms. In the last three years, the patient was treated by Valproic acid as a mood stabilizer. Because of the unavailability of this molecule, carbamazepine was prescribed in combination with antipsychotics. Three days later, the patient developed a high fever, hypotension, a pruritus, a facial oedema, a skin rash associated to lymphadenopathy. Laboratory findings showed a lymphopenia, eosinophilia and elevated liver chemistries. In order to define the case, RegiSCAR scoring system was used, and our case is categorized as probable with a score of five. Carbamazepine was discontinued upon clinical manifestationsand the patient was treated with systemic antihistaminic treatment associated to methylprednisolone with a good outcome. After 3 weeks, clinical and biological improvement were noted. CONCLUSIONS: Despite the absence of a delayed onset, typically between 3 weeks and 3months, we can diagnose dress syndrome 3 days after carbamazepine intake. This case highlights that psychiatrists should be aware of the risk of early onset dress syndrome associated with carbamazepine and they should monitor for warning symptoms from treatment initiation. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9479778/ http://dx.doi.org/10.1192/j.eurpsy.2021.2047 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kraiem, M.
Charfi, N.
Mhiri, E.
Gassara, I.
Omri, S.
Smaoui, N.
Feki, R.
Zouari, L.
Thabet, J. Ben
Bouali, M. Maalej
Maalej, M.
Dress syndrome following carbamazepine exposure: A very early onset
title Dress syndrome following carbamazepine exposure: A very early onset
title_full Dress syndrome following carbamazepine exposure: A very early onset
title_fullStr Dress syndrome following carbamazepine exposure: A very early onset
title_full_unstemmed Dress syndrome following carbamazepine exposure: A very early onset
title_short Dress syndrome following carbamazepine exposure: A very early onset
title_sort dress syndrome following carbamazepine exposure: a very early onset
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479778/
http://dx.doi.org/10.1192/j.eurpsy.2021.2047
work_keys_str_mv AT kraiemm dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT charfin dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT mhirie dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT gassarai dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT omris dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT smaouin dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT fekir dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT zouaril dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT thabetjben dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT boualimmaalej dresssyndromefollowingcarbamazepineexposureaveryearlyonset
AT maalejm dresssyndromefollowingcarbamazepineexposureaveryearlyonset